Ralf Huss
4Patents
2h-index
7Co-inventors
37Inventor score
Filing activity: Feb 24, 2001 → Jan 28, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6361997B1 | Genetically modified CD34-negative adherently growing stem cells and their use in gene therapy | Chemistry; Metallurgy | 51 | Expired |
| US7998472B2 | CD34 stem cell-related methods and compositions | Human Necessities | 25 | Active |
| US11464806B2 | Genetically modified mesenchymal stem cells expressing an immune response-stimulating cytokine to attract and/or activate immune cells | Chemistry; Metallurgy | 1 | Active |
| US9255139B2 | Tissue inhibitor of metalloproteinases (TIMP) linked to glycosylphosphatidylinositol (GPI)-anchors for treatment of cancer and skin lesions | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.